Bio/Pharma Business

Advanco Acquires Vantage Consulting Group

June 15, 2023

Advanco’s acquisition of Vantage Consulting Group boosts its position as a provider of independent pharmaceutical serialization solutions.

Pistoia Alliance and Matador Japan Collaborate to Accelerate Research

June 15, 2023

The collaboration between the Pistoia Alliance and Matador Japan will work to accelerate research and promote access to a global pharmaceutical ecosystem.

AstraZeneca and Quell Therapeutics Strike Cell Therapy Development Deal

June 14, 2023

The deal, valued at more than $2 billion dollars, will see Quell Therapeutics develop various T-regulatory cell therapies for AstraZeneca.

Business of Being at BIO

June 08, 2023

BIO is a powerful business development conference that can help make a lot of deals become reality.

Biosimilar CDMO Capacity Increased in Samsung Biologics – Pfizer’s New Arrangement

June 08, 2023

The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.

Merck Files Lawsuit Against US Government

June 08, 2023

The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.

Sartorius and Waters Expand Analytics Collaboration

June 08, 2023

Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.

MilliporeSigma Invests €35 Million to Strengthen Biosafety Testing in Scotland

June 07, 2023

Under the €35 million (US$37 million) investment, MilliporeSigma will expand its sites in Glasgow and Stirling, Scotland, to increase biosafety testing for drug development and commercialization.

invoX Pharma Invests in pHion Therapeutics to Develop Next-Generation mRNA Vaccines

June 06, 2023

invoX Pharma has made a second tranche of investment in pHion Therapeutics to support further development of next-generation mRNA vaccines.

Lonza Acquires Synaffix in ADC Deal

June 06, 2023

Lonza will gain access to R&D capabilities, including payload and site-specific linker technology, through its acquisition of ADC company, Synaffix.